Clinical Trial Update: The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and pharmacodynamics study assessing single and multiple doses of SP2086 in adults with type 2 diabetes. The public status of the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SP2086

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: UNKNOWN